MedPath
NMPA Approval

Digoxin Injection

国药准字H20249590

December 1, 2024

Drug Information

地高辛注射液

注射剂

2ml:0.5mg

化学药品

December 1, 2024

Company Information

Applicant Company

江苏省扬州市扬州生物健康产业园健康一路9号

Manufacturing Company

江苏省扬州市扬州生物健康产业园健康一路9号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

地高辛注射液 - NMPA 批准文号 | MedPath